Brain aging remains one of the toughest puzzles in neuroscience. The accumulation of senescent cells, which stop dividing and release inflammatory molecules, is considered an important mechanism of age-related diseases, but exactly how this happens in the brain, where neurons hardly divide at all, was unclear. Alongside this work, the archive holds studies that examine cell aging through epigenetic landscapes, mitochondrial shape, and brain volume loss in Alzheimer's disease. This study stands apart: it links telomere stress to neuronal energy metabolism at the level of the whole brain and individual cells.
The authors used mice with a knockout of the Terc gene, which encodes the RNA component of telomerase. In such animals, telomeres shorten with each generation, reproducing accelerated aging. To build a molecular portrait of the aging brain, they performed RNA sequencing and mass spectrometry of hippocampal proteins from five-month-old third-generation (G3) mice. Mitochondrial function was assessed by oxygen consumption of isolated mitochondria on the Seahorse platform, and energy status by levels of ATP, ADP, and AMP using high-performance liquid chromatography. In addition, primary neurons were cultured and their reactive oxygen species, membrane potential, and viability were measured.
Proteomic analysis identified 433 differentially expressed proteins, with the oxidative phosphorylation pathway being the most significantly suppressed. The activity of respiratory chain complexes II, III, and IV in the hippocampus dropped by about 20%, and in nine-month-old second-generation mice, ATP levels and cellular energy charge fell. Yet there was almost no neuronal death: only in the subiculum and layer 5 of the cortex did cell numbers decrease by a few percent. In culture, neurons accumulated mitochondria with increased reactive oxygen species production and reduced ATP levels, but maintained normal respiration and response to stimulation.
The work shows that mitochondrial dysfunction in telomere-driven aging arises earlier than energy collapse and neuronal death. Unlike neighboring studies that focus on epigenetics or cell morphology, here the energy deficit is traced from molecular changes to functional consequences in specific brain regions. This shifts the emphasis from late stages of neurodegeneration to early, potentially reversible stages.
The next step could be to search for compensatory mechanisms that maintain ATP levels in young mice despite defects in the respiratory chain. Likely candidates are enhanced glycolysis or the use of lactate from astrocytes. If such mechanisms can be identified, stimulating them might delay the energy crisis in the aging brain.
The results are important for gerontology, neurology, and the development of senolytics, since they point to mitochondria as an early target. They may also help interpret biomarkers of brain aging.
It is necessary to test whether the mitochondrial defect persists in Alzheimer's disease models and whether it can be reversed pharmacologically.
For the neuroscience of aging, a key unresolved question is: why do some neurons survive for decades while others die under the same conditions? This work links regional vulnerability to energy reserve, which may explain the selectivity of neurodegeneration.
The brain makes up only about 2% of body mass but consumes roughly 20% of all oxygen. A 20% drop in mitochondrial activity in such an organ is equivalent to mild hypoxia.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.